A multi-center, randomized, double-blind, placebo-controlled, dose-ranging study of Colal-Pred in the treatment of patients with moderate to severe ulcerative colitis
Phase of Trial: Phase II
Latest Information Update: 27 Sep 2010
At a glance
- Drugs Prednisolone metasulfobenzoate sodium (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- 22 Jan 2010 Actual patient number (190) added as reported by ClinicalTrials.gov.
- 22 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 Oct 2009 New trial record.